Accès ouvert
2025
article
OpenAlex
Silan Huang, Lingli Huang, Dongsheng Zhang, Qi Jiang et autres
Aim: This study aimed to evaluate and compare the therapeutic efficacy and adverse effects of two sequential treatment strategies in patients with unresectable advanced pancreatic cancer (aPC), albumin-bound-paclitaxel plus gemcitabine administered follow by mFOLFIRINOX or SOXIRI (AG-F(S)FX m ) versus the reverse …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Lingli Huang, Xujia Li, Silan Huang, Qi Jiang et autres
Background The E26 transformation-specific (ETS) transcription factor family is widely expressed and implicated in tumorigenesis. Among them, ETV4 plays a crucial role in cancer progression. However, its broader impact on prognosis and immune regulation across different malignancies remains insufficiently understood. Methods Based …
cn
(code pays fourni par la source)
2024
article
OpenAlex
Silan Huang, Lingli Huang, Qi Jiang, Jiang Chang et autres
cn
(code pays fourni par la source)
2024
article
OpenAlex
Silan Huang, Lingli Huang, Guifang Guo
cn
(code pays fourni par la source)
2023
article
OpenAlex
Ze Wei, Lingli Huang, Xinyu Feng, Feng Cui et autres
cn
(code pays fourni par la source)
2015
conference-paper
OpenAlex
Xiaolong Liu, Lingli Huang, Xianying Chang
In view of the defect that the migration operator randomness is too strong to reduce the bacteria overall fitness, but not conducive to the overall optimization when bacteria foraging algorithm is in the optimization process. Then the pheromone of ant colony algorithm …
cn
(code pays fourni par la source)
Accès ouvert
2014
retraction
OpenAlex
Haihong Hao, Jie Liu, Xiuhua Kuang, Menghong Dai et autres
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
cn
(code pays fourni par la source)